no one says anything; everyone is on Zyprexa?
AI-text
Zyprexa (olanzapine) is a second-generation antipsychotic commonly prescribed to reduce or stop auditory hallucinations and voices associated with schizophrenia and bipolar disorder. It works by blocking dopamine receptors in the brain, which helps dampen the intensity of psychotic experiences, allowing users to think more clearly and reduce agitation.
Individual responses to the medication vary significantly:
Effectiveness: Many users report that Zyprexa turns down the "volume" of voices, making them less distressing or causing them to disappear entirely, particularly at higher doses (e.g., 20mg–40mg).
Limitations: For some, the medication only partially reduces symptoms or fails to eliminate voices completely, sometimes requiring dose adjustments or combination therapy.
Side Effects: A common trade-off is significant sedation (excessive sleepiness) and weight gain, which can impact quality of life and adherence.
Rarity of Paradoxical Effects: While extremely rare, there are anecdotal reports of individuals experiencing new or worsened hallucinations after starting Zyprexa, though this is not the standard therapeutic outcome.
km
npub1ft…43gst
2026-10-05 13:49:54 UTC
in reply to nevent1q…40k5
Author Public Key
npub1ft5fucemz407r284323h56rsftws05wn3pqnudvda2ddp2mfhrust43gstPublished at
2026-10-05 13:49:54 UTCEvent JSON
{
"id": "260e88a962c624013357109eaa0da7abf9b18f6728514bcd6f6eee2779bc9047",
"pubkey": "4ae89e633b155fe1a8f58aa37a68704add07d1d388413e358dea9ad0ab69b8f9",
"created_at": 1791208194,
"kind": 1,
"tags": [
[
"p",
"4ae89e633b155fe1a8f58aa37a68704add07d1d388413e358dea9ad0ab69b8f9"
],
[
"e",
"3560060d41ba2ce5523ac8e4f511ca00b068d176d8150496a692566653a84837",
"",
"reply",
"4ae89e633b155fe1a8f58aa37a68704add07d1d388413e358dea9ad0ab69b8f9"
],
[
"e",
"e33b18d0c0a6f971d8d40d953973aa9f1aed4219417f15f5e0594f7aaacc1ee1",
"",
"root",
"4ae89e633b155fe1a8f58aa37a68704add07d1d388413e358dea9ad0ab69b8f9"
],
[
"proxy",
"https://km.produkti.se/objects/873f9e16-1299-4b35-b152-505e02d0f599",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://km.produkti.se/objects/873f9e16-1299-4b35-b152-505e02d0f599",
"pink.momostr"
],
[
"-"
]
],
"content": "no one says anything; everyone is on Zyprexa?\r\n\r\nAI-text\r\n\r\nZyprexa (olanzapine) is a second-generation antipsychotic commonly prescribed to reduce or stop auditory hallucinations and voices associated with schizophrenia and bipolar disorder. It works by blocking dopamine receptors in the brain, which helps dampen the intensity of psychotic experiences, allowing users to think more clearly and reduce agitation. \r\n\r\nIndividual responses to the medication vary significantly:\r\n\r\nEffectiveness: Many users report that Zyprexa turns down the \"volume\" of voices, making them less distressing or causing them to disappear entirely, particularly at higher doses (e.g., 20mg–40mg).\r\n\r\nLimitations: For some, the medication only partially reduces symptoms or fails to eliminate voices completely, sometimes requiring dose adjustments or combination therapy.\r\n\r\nSide Effects: A common trade-off is significant sedation (excessive sleepiness) and weight gain, which can impact quality of life and adherence.\r\n\r\nRarity of Paradoxical Effects: While extremely rare, there are anecdotal reports of individuals experiencing new or worsened hallucinations after starting Zyprexa, though this is not the standard therapeutic outcome.",
"sig": "ec661e8ce79c00423b8504b96378ec12dcf751c374628fcef7dce03e15f2004ce703aac538900d6bf1c466fa44f9a62976d0b64277c2a250c1855ed6428b3ebb"
}